SCHEMBL21292765

SCHEMBL21292765

O=C(NN=Cc1cccc([N+](=O)[O-])c1)c1ccc(O)cc1O

nearest known ligand 0.70

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PHGDH O43175 1/20 0.70
CYP1A2 P05177 1/20 0.66
CYP2C19 P33261 1/20 0.66
KMT2A Q03164 4/20 0.62
MEN1 O00255 3/20 0.62
POLB P06746 2/20 0.62
MAPT P10636 9/20 0.61
LMNA P02545 4/20 0.61
NPSR1 Q6W5P4 2/20 0.61
DUSP3 P51452 1/20 0.61
PTPN5 P54829 1/20 0.61
PTPN11 Q06124 1/20 0.61
RAB9A P51151 4/20 0.61
NPC1 O15118 4/20 0.61
SMN1; SMN2 Q16637 3/20 0.60
SENP1 Q9P0U3 1/20 0.58
ALDH1A1 P00352 2/20 0.58
RECQL P46063 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21292762 1.00 PHGDH (0.70) PHGDHCYP1A2CYP2C19KMT2AMEN1
SCHEMBL21292815 0.87 PHGDH (0.74) PHGDHKMT2AMEN1POLBMAPT
SCHEMBL21292817 0.87 PHGDH (0.74) PHGDHKMT2AMEN1POLBMAPT
SCHEMBL21292689 0.85 NPSR1 (0.80) PHGDHKMT2AMEN1POLBMAPT
SCHEMBL21292691 0.85 NPSR1 (0.80) PHGDHKMT2AMEN1POLBMAPT
SCHEMBL14583880 0.82 PHGDH (1.00) PHGDHKMT2AMEN1MAPTLMNA
SCHEMBL21292676 0.82 PHGDH (1.00) PHGDHKMT2AMEN1MAPTLMNA
SCHEMBL29359751 0.82 PHGDH (1.00) PHGDHKMT2AMEN1MAPTLMNA
SCHEMBL20299057 0.81 MEN1 (0.75) PHGDHKMT2AMEN1POLBMAPT
SCHEMBL20115424 0.81 MEN1 (0.75) PHGDHKMT2AMEN1POLBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10722489-B2 D-3-phosphoglycerate dehydrogenase allosteric inhibitor and use thereof PEKING UNIVERSITY (CN) 2020-07-28 US disclosed
US-20200054593-A1 D-3-PHOSPHOGLYCERATE DEHYDROGENASE ALLOSTERIC INHIBITOR AND USE THEREOF UNIV BEIJING (CN) 2020-02-20 US disclosed
US-20190262303-A1 D-3-PHOSPHOGLYCERATE DEHYDROGENASE ALLOSTERIC INHIBITOR AND USE THEREOF UNIV BEIJING (CN) 2019-08-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10722489-B2 D-3-phosphoglycerate dehydrogenase allosteric inhibitor and use thereof MDH2, MDH1, DLD PHGDH 4/4885CYP1A2 2420/4885CYP2C19 3028/4885
US-20200054593-A1 D-3-PHOSPHOGLYCERATE DEHYDROGENASE ALLOSTERIC INHIBITOR AND USE THEREOF MDH2, MDH1, DLD PHGDH 4/4885CYP1A2 2420/4885CYP2C19 3028/4885
US-20190262303-A1 D-3-PHOSPHOGLYCERATE DEHYDROGENASE ALLOSTERIC INHIBITOR AND USE THEREOF MDH2, MDH1, DLD PHGDH 4/4885CYP1A2 2420/4885CYP2C19 3028/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.